Previous studies have shown that MD patients can be subgrouped according to their IL-1β levels [9] and that these patients show a different epigenetic signature [4], therefore we wanted to evaluate if these patients also presented transcriptomic differences. The gene discussed is IL1B; the disease is Menkes disease.